Learn more about immunotherapy treatment standards for squamous cell carcinoma of the head and neck (HNSCC) and hear about the Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) in this free one-hour webinar. SITC hosted this session on Wednesday, July 24, featuring members of the Cancer Immunotherapy Guidelines – Head and Neck Subcommittee.
Key points from SITC's Cancer Immunotherapy Guidelines Head and Neck have been distilled into a Pocket Guide. This condensed, easily accessible version of the full Cancer Immunotherapy Guideline is a quick-reference tool that will soon be available in both digital and print.
Download SITC's Cancer Immunotherapy Guidelines Head and Neck Pocket Guide on any desktop or mobile device today.*
*Available only through the Guideline Central App.
ORDER Digital/Print Guide
R. Bryan Bell, MD, DDS, FACS — Earle A. Chiles Research Institute, Providence Cancer Institute
Barbara A. Burtness, MD — Yale University School of Medicine
Maura L. Gillison, MD, PhD — The University of Texas MD Anderson Cancer Center
Kevin Harrington, PhD, FRCP, FRCR — The Institute of Cancer Research
Quynh-Thu Le, MD, FACR, FASTRO — Stanford University
Nancy Y. Lee, MD — Memorial Sloan Kettering Cancer Center
Rom Leidner, MD — Earle A. Chiles Research Institute, Providence Cancer Institute
Rebecca L. Lewis, CRNP — UPMC Hillman Cancer Center
Lisa Licitra, MD — Fondazione IRCCS Instituto Nazionale dei Tumori
Hisham Mehanna, PhD — Institute of Head and Neck Studies and Education
Loren K. Mell, MD — Dept. of Radiation Medicine and Applied Sciences, UC-San Diego
Adam Raben, MD — Christiana Care Health System
Andrew G. Sikora, MD, PhD — Baylor College of Medicine
Ravindra Uppaluri, MD, PhD — Dana-Farber Cancer Institute
Fernanda Whitworth — Co-founder of The Immunotherapy Foundation
Dan P. Zandberg, MD — UPMC Hillman Cancer Center
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com